NGS Sequencing Panels: advances in oncological diagnosis through tissue biopsies
In the field of oncology, precision medicine has transformed the way we approach cancer. One of the most powerful tools in this arsenal is NGS (Next-Generation Sequencing) panels, which allow for a detailed analysis of genetic alterations within tumors. At OncoDynamics, we specialize in leveraging these technologies to offer advanced molecular diagnostics that guide personalized […]
Cancer Sequencing Panels: What They Are, How They Work, and When to Get Them
Cancer sequencing panels are key molecular tools in modern oncology. They make it possible to detect genetic alterations relevant for diagnosis, prognosis, and the selection of targeted therapies. In this article, I explain what an oncology sequencing panel is, how it identifies mutations, and when a patient should consider having one done. What is a […]
Ex vivo assays in metastatic colon cancer (mCRC)
Functional ex vivo assays applied to metastatic colon cancer (mCRC) directly evaluate a patient’s tumor response to chemotherapeutic agents before they are administered. This personalized medicine approach provides actionable clinical information that complements molecular testing and supports therapy selection based on real efficacy in tumor tissue. What are functional ex vivo assays? Ex vivo assays […]
Oncologic Biomarkers: What They Are, Types, and the Most Common in Cancer
Oncologic biomarkers are biological measurements that indicate the presence, progression, or response to treatment of a cancer. Their usefulness includes diagnosis, patient stratification, prediction of therapeutic response, and disease monitoring. In modern oncology, oncologic biomarkers are the foundation of personalized medicine, enabling the selection of targeted therapies, optimizing clinical trials, and improving disease follow-up. What […]